Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clarivate (CLVT) Cash & Equivalents: 2017-2025

Historic Cash & Equivalents for Clarivate (CLVT) over the last 7 years, with Sep 2025 value amounting to $318.7 million.

  • Clarivate's Cash & Equivalents fell 17.97% to $318.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $318.7 million, marking a year-over-year decrease of 17.97%. This contributed to the annual value of $295.2 million for FY2024, which is 20.37% down from last year.
  • Per Clarivate's latest filing, its Cash & Equivalents stood at $318.7 million for Q3 2025, which was down 12.11% from $362.6 million recorded in Q2 2025.
  • Over the past 5 years, Clarivate's Cash & Equivalents peaked at $2.6 billion during Q2 2021, and registered a low of $295.2 million during Q4 2024.
  • Over the past 3 years, Clarivate's median Cash & Equivalents value was $364.2 million (recorded in 2023), while the average stood at $366.1 million.
  • Per our database at Business Quant, Clarivate's Cash & Equivalents soared by 320.63% in 2021 and then crashed by 85.95% in 2022.
  • Clarivate's Cash & Equivalents (Quarterly) stood at $430.9 million in 2021, then dropped by 17.20% to $356.8 million in 2022, then grew by 3.90% to $370.7 million in 2023, then decreased by 20.37% to $295.2 million in 2024, then declined by 17.97% to $318.7 million in 2025.
  • Its Cash & Equivalents stands at $318.7 million for Q3 2025, versus $362.6 million for Q2 2025 and $354.0 million for Q1 2025.